Last updated: October 31, 2024
Sponsor: University of Aarhus
Overall Status: Completed
Phase
N/A
Condition
Polycystic Ovarian Syndrome
Reproductive Health
Treatment
3-OHB (KE4)
water
Clinical Study ID
NCT05762822
1-10-72-217-22
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
PCOS diagnosis
age >18 years
Exclusion
Exclusion Criteria:
Medications affecting sex hormones (e.g. contraceptives, dopamine agonists, etc) orglucose metabolism (e.g. saxenda).
Anemia (Hgb < 6.0 mM)
Practicing ketogenic diets (e.g., low-carb diet, fasting regimes)
Inability to understand Danish or English
Diabetes
Ongoing cancer or other acute/chronic serious diseases (PI will determine)
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: 3-OHB (KE4)
Phase:
Study Start date:
May 10, 2023
Estimated Completion Date:
October 30, 2024
Study Description
Connect with a study center
Department of Diabetes and Hormone Diseases (DoH)
Aarhus N, 8200
DenmarkSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.